| Published Application/Species/Sample/Dilution | Reference |
|---|
- flow cytometry; human; loading ...; fig 6
| Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher |
- flow cytometry; human; loading ...; fig s3a
| Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher |
- flow cytometry; human; 1:100; loading ...; fig 5a
| Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher |
- flow cytometry; human; fig 7
| Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher |
- flow cytometry; human; fig 1
| Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher |
| Wang X, Li W, Zhu D, Zhao H, Chen P, Chen X. Characterization of human peripheral blood γδ T cells in patients with sepsis. Exp Ther Med. 2020;19:3698-3706 pubmed publisher |
| Ogongo P, STEYN A, Karim F, Dullabh K, Awala I, Madansein R, et al. Differential skewing of donor-unrestricted and γδ T cell repertoires in tuberculosis-infected human lungs. J Clin Invest. 2020;130:214-230 pubmed publisher |
| Moulin M, Alguacil J, Gu S, Mehtougui A, Adams E, Peyrottes S, et al. V?9V?2 T cell activation by strongly agonistic nucleotidic phosphoantigens. Cell Mol Life Sci. 2017;74:4353-4367 pubmed publisher |
| de Bruin R, Stam A, Vangone A, van Bergen en Henegouwen P, Verheul H, Sebestyen Z, et al. Prevention of V?9V?2 T Cell Activation by a V?9V?2 TCR Nanobody. J Immunol. 2017;198:308-317 pubmed |
| de Bruin R, Lougheed S, van der Kruk L, Stam A, Hooijberg E, Roovers R, et al. Highly specific and potently activating V?9V?2-T cell specific nanobodies for diagnostic and therapeutic applications. Clin Immunol. 2016;169:128-138 pubmed publisher |
| Fazio J, Quabius E, Muller A, Adam Klages S, Wesch D, Sebens S, et al. Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis). Clin Immunol. 2013;149:65-72 pubmed publisher |
| Correia D, Fogli M, Hudspeth K, da Silva M, Mavilio D, Silva Santos B. Differentiation of human peripheral blood V?1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood. 2011;118:992-1001 pubmed publisher |
